0      0

Regulatory Updates on Biotechnological and Biologic Products

‐ Jun 2, 2020 9:30am

Credits: None available.

Regulatory expectations related to biotechnology and biological products are continually evolving both within mature and emerging regulatory agencies. This session will provide a snapshot of recent regulatory changes across the global landscape. Invited speakers will provide a sampling of some of the recent regulatory responses related to the ongoing COVID-19 pandemic, discuss the rapidly evolving regulatory landscape in China, and highlight some of the recent trends related to sterile products in the United States.




Credits: None available.

You must be logged in and own this session in order to post comments.